The analgesic effect of thymoquinone in the reserpine-induced experimental fibromyalgia model
Open Access
- 30 June 2026
- journal article
- Published by Cukurova Anestezi ve Cerrahi Bilimler Dergisi in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
- Vol. 9 (2) , 349-354
Abstract
Aim: Fibromyalgia is a chronic pain syndrome characterized by widespread pain and sensory hypersensitivity, for which effective and well-tolerated treatments remain limited. This study aimed to evaluate the analgesic effect of thymoquinone (TQ) in a reserpine-induced experimental fibromyalgia model in rats.Methods: Male Wistar rats were randomly allocated into three groups (n = 6 per group): control, reserpine, and reserpine + thymoquinone. Fibromyalgia-like pain was induced by subcutaneous administration of reserpine (1 mg/kg) once daily for three consecutive days. Thymoquinone (100 mg/kg) was administered orally four days after the final reserpine injection. Mechanical allodynia and thermal hyperalgesia were assessed using the von Frey filament test and the hot-plate test, respectively, at baseline and at 30, 60, 120, and 180 minutes following treatment. Behavioral assessments were performed by an investigator blinded to group allocation. Non-parametric statistical analyses were applied.Results: Baseline mechanical and thermal nociceptive thresholds did not differ significantly among groups. Thymoquinone treatment resulted in a significant increase in mechanical withdrawal thresholds compared with both control and reserpine-only groups at 60, 120, and 180 minutes (p < 0.01), indicating a marked attenuation of reserpine-induced mechanical allodynia. In contrast, no statistically significant differences were observed between groups in hot-plate latency times at any time point, although numerically higher latencies were noted in the thymoquinone-treated group at later assessments.Conclusions: Thymoquinone exerts a significant analgesic effect on mechanical allodynia in a reserpine-induced fibromyalgia model, suggesting its potential as a novel therapeutic agent for fibromyalgia-associated pain. Further studies are warranted to clarify its mechanism of action and modality-specific analgesic profile.Keywords
This publication has 14 references indexed in Scilit:
- Novel insights into the molecular mechanisms underlying anti-nociceptive effect of myricitrin against reserpine-induced fibromyalgia model in rats: Implication of SIRT1 and miRNAsJournal of Ethnopharmacology, 2024
- Reserpine-induced altered neuro-behavioral, biochemical and histopathological assessments prevent by enhanced antioxidant defence system of thymoquinone in miceMetabolic Brain Disease, 2021
- FibromyalgiaJAMA, 2014
- Thymoquinone: Potential cure for inflammatory disorders and cancerBiochemical Pharmacology, 2012
- Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: A putative animal model of fibromyalgiaPain, 2009
- Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-admintstered mitragynine in miceLife Sciences, 1998
- Central antinociceptive effects of mitragynine in mice: contribution of descending noradrenergic and serotonergic systemsEuropean Journal of Pharmacology, 1996
- Quantitative assessment of tactile allodynia in the rat pawJournal of Neuroscience Methods, 1994
- A modified hot-plate test sensitivie to mild analgesicsBehavioural Brain Research, 1986
- Ethical guidelines for investigations of experimental pain in conscious animalsPain, 1983